Related Experiment Video
Updated: May 9, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
Bioelectronics based on antibody-conjugated graphene field-effect transistor for response of Staphylococcal
Kyung Ho Kim1, Eun-Ha Hwang2, Ju Hong Jang3
1SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, Suwon 16419, Republic of Korea.
Abstract:
Staphylococcal enterotoxin B (SEB) is a potent toxin that is produced by Staphylococcus aureus and is classified as an agent for biological weapons. Various nanotechnology-based biosensors have been developed to respond to SEB-based biological weapons; however, these biosensors exhibit various limitations. A novel chimeric antibody was developed from SEB-specific hybridoma clones that were generated using native-like SEB antigen expressed via a baculovirus system. The chimeric antibody exhibited high binding specificity and subnanomolar affinity and was subsequently conjugated onto a graphene field-effect transistor-based bioelectronic (SEB bioelectronic). This device exhibited high performance with a limit of detection of 1 pg/mL and a detection range of 1 pg/mL to 100 ng/mL, demonstrating superior specific detection performance even in the presence of various interference toxin substances at 103 times higher concentrations. Moreover, the SEB bioelectronic was evaluated using nonhuman primate infection models, and the detection performance was investigated based on those for standard SEB substances. These results indicate that the SEB bioelectronic can be utilized for noncontact SEB detection in SEB-exposed onsite locations and can be applied for bioelectronic development to respond to other biological weapons through bioprobe exchanges.
More Related Videos
07:51Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
Published on: February 1, 2022
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022